Visterra

Visterra

Visterra is a biotechnology company that uses ...

Other | United States of America | Access to Information |

 

Overview

Visterra's technology is powered by Atomic Interaction Network (AIN) analysis, which are computational tools and techniques. For protein and glycoprotein targets, their Hierotope™ Platform is able to identify the region of the protein, or epitope, which is structurally "constrained," and thus prevented from mutation over time or under immunological or therapeutic pressure. This conserved and constrained epitope, or hierotope, becomes an ideal target against which they design a novel therapeutic to effectively and durably combat the disease. For glycan targets, their Hierotope™ Platform is able to identify structural and conformational constraints of the intended target, against which they then design a novel therapeutic to effectively and durably combat the disease.

Industry

Legal Structure

Operating Status

Employees

Other Operating

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

One Kendall Square
Suite B3301
Cambridge, Massachusetts 02139
United States of America



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.